T1	Participants 81 131	patients with Stage IV lung and colorectal cancer:
T2	Participants 512 584	Sixty-six adults with Stage IV lung or colorectal cancer were randomized
T3	Participants 1316 1425	Three participants dropped out and seven died (five in the intervention and two in the control group, P=0.28)
